A phase II study assessing the safety and efficacy of ASP1650 in male patients with incurable platinum refractory germ cell tumors Meeting Abstract


Authors: Adra, N.; Vaughn, D. J.; Einhorn, L.; Hanna, N. H.; Rosales, M.; Arozullah, A.; Feldman, D. R.
Abstract Title: A phase II study assessing the safety and efficacy of ASP1650 in male patients with incurable platinum refractory germ cell tumors
Meeting Title: 2020 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 6 Suppl.
Meeting Dates: 2020 Feb 13-15
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-20
Language: English
ACCESSION: WOS:000529525900037
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.6_suppl.TPS424
Notes: Meeting Abstract: TPS424 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    340 Feldman